Adagene (ADAG) Treasury Shares (2021 - 2024)

Adagene's (ADAG) quarterly Treasury Shares came in at -$4.0 in Q2 2024.

Adagene (ADAG) Treasury Shares (2021 - 2024) Analysis & Trends

Adagene (ADAG) has 1 years of Treasury Shares data on file, last reported at -$4.0 in Q2 2024.

  • On a quarterly basis, Treasury Shares changed 0.0% year-over-year to $4.0 in Q4 2023; TTM through Dec 2023 was $4.0, a 0.0% change from a year earlier, with the FY2023 full-year figure at $4.0, changed 0.0% from the prior year.
  • Treasury Shares for Q4 2023 stood at $4.0, up from -$4.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for ADAG reached as high as -$4.0 in Q2 2024 and fell as low as -$4.0 in Q2 2024.
  • Historically, Treasury Shares has averaged -$845096.8 across 3 years, with a median of $4.0 in 2022.
  • Across the five-year window, Treasury Shares slumped 100.0% in 2022 and changed 0.0% in 2023, its largest moves.
  • Year by year, Treasury Shares stood at $619605.0 in 2021, then slumped by 100.0% to $4.0 in 2022, then changed by 0.0% to $4.0 in 2023.
  • Per Business Quant data, the three most recent Treasury Shares figures were $4.0 in Q4 2023, -$4.0 million in Q2 2023, and $4.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -21,709.08
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 265,401.92
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 5.14 Mn
10 Adagene 198.85 Mn 198.85 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -4.00
Jun 30, 2024 -4.00
Dec 31, 2023 4.00
Dec 31, 2023 4.00
Jun 30, 2023 -4.00 Mn
Jun 30, 2023 -4.00 Mn
Dec 31, 2022 4.00
Dec 31, 2022 4.00
Dec 31, 2021 619,605.00
Dec 31, 2021 619,605.00